I O Institution Supplement U.S. Ditmeut of Justice Federal Bureau of Prisons Afetropolaan Correctional Center New York NY 10007 OPI: NUMBER: DATE: SUBJECT: HSA NYM 6031.01C April 10, 2007 Detoxification and Treatment Programs 1. PURPOSE: To establish procedures to ensure the Metropolitan Correctional Center, New York, is in compliance with federal regulations for methadone detoxification and detoxification from other abuse substances, i.e., opiates, alcohol, and narcotics. 2. REFERENCE: Program Statement 6031.01, Health Services Manual, dated January 15, 2005, Drug Enforcement Administration (DEA) regulatory controls relating to registration, security and record keeping of institutions having a narcotic treatment program. Institutional Supplement 6501.5(A), is rescinded. 3. INTRODUCTION: The Clinical Director will establish guidelines for evaluation and treatment of inmates who require detoxification from mood and mind altering substances such as alcohol, opiates, hypnotics, sedatives, etc. The guidelines will include specific detoxification protocols to be implemented upon order of medical staff. Treatment and supportive measures will permit withdrawal with minimal physiological and physical discomfort. Metropolitan Correctional Centers, Metropolitan Detention Centers, Federal Transportation Centers and jail units may provide methadone detoxification if clinically indicated. This program requires special registration. If an institution has a methadone detoxification program then the institution Chief Pharmacist will complete and maintain registration for a methadone program. Methadone is permitted to be administered or dispensed only for detoxification or temporary treatment of patients. If Methadone is administered for treatment of heroin dependence, for more than three weeks, the procedure passes from treatment of the acute withdrawal syndrome (detoxification) to a maintenance program. This institution has the authority to